Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Elezanumab by AbbVie for Acute Ischemic Stroke: Likelihood of Approval
Elezanumab is under clinical development by AbbVie and currently in Phase II for Acute Ischemic Stroke. According to GlobalData, Phase...